However, past pancreatitis is not a contraindication for these agents, and contrary to the previous warning, recent studies have not shown an increased pancreatic risk associated with GLP-1 RAs, leading to ongoing revisions in treatment guidelines
Discovery of the once-weekly GLP-1 analogue semaglutide
Triglyceride reductions averaging 28% approach what some prescription medications achieve, while LDL cholesterol drops by approximately 12%
www.nature.com , Torekov, S
Are there additional benefits of drinking water beyond preventing dehydration
Dan Bell: In the pharma supply chain, we implement numerous strategies to safeguard the quality and security of existing GLP-1 products and ensure their continued availability to patients